Work

A Phase One, Open Label, Multi-Dose Study To Evaluate The Safety, Tolerability, And Biologic Effects Of Three Doses Of IW001 In Patients With Idiopathic Pulmonary Fibrosis (IPF)

Year: 2012

Type: conference-abstract

DOI: 10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a4588

Authors: Katia Rothhaar, Terrence Chew, Sarah Frye, Michael Klemsz, Wade Lange, David S. Wilkes

Institution: ImmuneWorks (United States)

Language: English

Topic: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2327246100

Cites:

Cited by:

Related to: 10